Navigation Links
Closer Analysis Shows Consumer Groups Make Gains in Stem Cell Patent Challenges Against WARF; Appeal Still Planned Against Narrowed Claims

SANTA MONICA, Calif., Feb. 28 /PRNewswire-USNewswire/ -- Closer analysis of the patent office "non-final" decision on a human embryonic stem cell patent held by the Wisconsin Alumni Research Foundation (WARF) shows the following gains made for researchers:

-- The original broad patent was abandoned showing it was underserved and new amended claims have been narrowed.

-- The original patent covered all embryonic stem cells no matter how they are derived, but the amended "non-final" ruling, while permitting the patent, narrowed the claim only to stems cells derived from pre-implantation embryos.

-- The newest stem cell research technology -- Induced Pluripotent Stem Cells (IPS cells) -- would clearly not be covered by the narrowed patent.

-- Stem cells derived from fetal tissue could have been claimed under the old patent, but now cannot be.

Consumer groups still believe the narrowed patent is invalid and should be revoked. They intend to challenge the latest patent office decision.

The challenge brought by the Foundation for Taxpayer and Consumer Rights (FTCR) and the Public Patent Foundation (PUBPAT) already produced a major victory for consumers and researchers when WARF announced in January 2007 that it was substantially easing its licensing requirements on stem cells. The groups filed re-examination requests on three patents, the '913, '806 and '780 in July 2006.

"We've made progress in thwarting WARF's overreaching patents and changing the organization's aggressive behavior toward the research community," said John M. Simpson, FTCR Stem Cell Project Director. "We are in this for the long haul."

The groups said they would appeal any later final decision by the examiner supporting the amended claims to the Patent and Trademark Office's Board of Appeals, which frequently overturns the decision made by examiners. The groups also have the right to appeal any decision of that board to the U.S. Circuit Court for the Federal Circuit, if necessary.

The "non-final office decision" in the inter partes re-examination of the '913 patent was posted late Wednesday on the PTO's website.

"The examiner based his decision on his own belief that it would not have been obvious to isolate human stem cells using widely known methods to isolate mouse stem cells, which contradicts the sworn testimony that we provided of four renowned stem cell embryologists who were doing such work," said Dan Ravicher, PUBPAT Executive Director. "Thus, the examiner took his own opinion over the opinions of our four leading stem cell scientist witnesses."

Joining the two consumer groups in the challenge from the beginning was Dr. Jeanne Loring, now of the Scripps Institute. After the initial rejection, Dr. Alan Trounson, then of Australia's Monash University and now president of the California Institute for Regenerative Medicine, Dr. Douglas Melton of Harvard and Dr. Chad Cowan of Harvard filed affidavits supporting the challenge.

"WARF executives were acting like arrogant bullies blinded by dollar signs," said Simpson. "Our challenge has engendered a more co-operative stance on their part."

Decisions are pending on the '780 and '806 patents. No other country recognizes the three WARF patents.

The Foundation for Taxpayer and Consumer Rights is California's leading non-profit and non-partisan consumer watchdog group. For more information visit us on the web at:

The Public Patent Foundation is a not-for-profit legal services organization that represents the public's interests against the harms caused by the patent system, particularly the harms caused by wrongly issued patents and unsound patent policy. For more information, visit us on the web at

SOURCE Foundation for Taxpayer and Consumer Rights
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. UBs bioblower closer to protecting soldiers from biological attack
2. Bug guts map brings scientists closer to understanding different bugs role in the body
3. Study Gets Closer to Origins of Leukemia
4. Research Gets Closer to Origin of Parkinsons Disease
5. UGA researchers 1 step closer to elusive cancer vaccine
6. HASP Online Provides Free Job Safety Analysis Tool Available Online
7. Doing Angioplasty Long After Heart Attack Still Worth It, Analysis Shows
8. By color-coding atoms, new Cornell electron microscope promises big advance in materials analysis
9. Global Analysis of Human DNA Tracks Migration, Identity
10. DNA Analysis Could Help Customize Treatments for MS
11. Congressional Budget Office Analysis of HR971 Rejects Pharmacy Benefit Managers Bogus Claim Bill Would Cost $29 Billion Over 5 Years
Post Your Comments:
(Date:10/13/2017)... ... 2017 , ... The International Association of Eating Disorders Professionals ... the field of eating disorders, announces the opening of early registration for the ... at the Omni Resort at ChampionsGate. , The annual iaedp™ Symposium ...
(Date:10/13/2017)... ... October 13, 2017 , ... Lori R. Somekh, founder ... of ElderCounsel, a national organization of elder law and special needs planning attorneys. “Membership ... rules. It also provides a forum to network with elder law attorneys nationwide,” said ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The Visiting Nurse ... Market. Featuring a collection of specialty vendors and unique items from across the nation, ... quality-focused health and wellness services offered by the VNA. The boutique will be ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Yisrayl Hawkins, Pastor ... that explains one of the most popular and least understood books in the Holy ... and puzzling descriptions that have baffled scholars for centuries. Many have tossed it off ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
Breaking Medicine News(10 mins):
(Date:10/10/2017)... , Oct. 10, 2017  NDS received FDA 510(k) clearance ... a medical-grade battery-powered display stand specifically designed for endoscopy environments. An ... technology into a clinical solution to support the improvement of patient ... Innovative Design ... Wireless Solution ...
(Date:10/4/2017)...  South Korean-based healthcare product Development Company I.M. Lab ... Kickstarter. The device will educate the user about ,proper, ... efficiency compared to the dated and pricey CPR training ... of the compression for a more informed CPR training. ... raise $5,000. cprCUBE ...
(Date:10/2/2017)... Lilly and Company (NYSE: LLY ) will ... 2017 on Tuesday, October 24, 2017. Lilly will also ... investment community and media to further detail the company,s ... at 9 a.m. Eastern time. Investors, media and the ... conference call through a link that will be posted ...
Breaking Medicine Technology: